Adial Pharmaceuticals- Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of Ad04 for Treatment of Alcohol Use Disorder
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.